Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson’s disease

Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors

Douglas S. Johnson, Eranthie Weerapana, Benjamin F. Cravatt · Future Medicinal Chemistry · 2010 · 383 citations · Full text

Medicinal Chemistry, Covalent Inhibitors, Covalent Inhibitor +13

New Frontiers in Selective Human MAO-B Inhibitors

Simone Carradori, Romano Silvestri · Journal of Medicinal Chemistry · 2015 · 214 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +14

Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function

Carla Ferrada, Sergi Ferré, Vicent Casadó et al. · Neuropharmacology · 2008 · 173 citations · Full text

Neuropsychology, Psychiatry, Medicine +13

Recent advances in ether dealkylation

Steven A. Weissman, Daniel Zewge · Tetrahedron · 2005 · 169 citations

Physics, Natural Sciences, Exotic State +2

The brain H3-receptor as a novel therapeutic target for vigilance and sleep–wake disorders

Régis Parmentier, Christelle Anaclet, C. Guhennec et al. · Biochemical Pharmacology · 2007 · 168 citations

Sleep Disorders, Sleep Health, Novel Therapeutic Target +16